BGI
BGI Genomics Forges Partnerships for Precision Medicine in Latin America
Through the collaborations, the Chinese NGS service provider is introducing its oncology and noninvasive prenatal tests to Brazil, Argentina, and Chile.
Reporting 2022 earnings last week, the Chinese genomics firm revealed its new entities on multiple continents as part of its global expansion strategy.
BGI Genomics, Zentya Partner to Launch PCR Fecal Test for Colorectal Cancer in Slovakia
ColoTect 1.0 is a fecal assay that can trace abnormal colorectal cancer DNA-methylation biomarkers from fecal samples using methylation-specific PCR technology.
BGI Genomics Gets Australian Regulatory Approval for Multiplexed SARS-CoV-2, Influenza Test
The RT-PCR-based test is designed to simultaneously detect and differentiate SARS-CoV-2, influenza A, and influenza B from throat swab samples.
In Brief This Week: Pierian, PerkinElmer, Decode Health, Quest, Nucleix, More
News items for the week of Oct. 17, 2022.
Sep 2, 2022
BGI Gets CE-IVD Mark for Thalassemia Test
Feb 14, 2020